275 related articles for article (PubMed ID: 31247015)
61. Gender, histology, and time of diagnosis are important factors for prognosis: analysis of 1499 never-smokers with advanced non-small cell lung cancer in Japan.
Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Kawahara M; Maruyama Y
J Thorac Oncol; 2010 Jul; 5(7):1011-7. PubMed ID: 20502360
[TBL] [Abstract][Full Text] [Related]
62. Diameter of non-small cell lung cancer correlates with long-term survival: implications for T stage.
Mery CM; Pappas AN; Burt BM; Bueno R; Linden PA; Sugarbaker DJ; Jaklitsch MT
Chest; 2005 Nov; 128(5):3255-60. PubMed ID: 16304270
[TBL] [Abstract][Full Text] [Related]
63. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
Koch A; Fohlin H; Sörenson S
J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
[TBL] [Abstract][Full Text] [Related]
64. Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: Comparing survival outcomes in adenocarcinoma and squamous cell carcinoma.
Abel S; Hasan S; White R; Schumacher L; Finley G; Colonias A; Wegner RE
Lung Cancer; 2019 Feb; 128():127-133. PubMed ID: 30642444
[TBL] [Abstract][Full Text] [Related]
65. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
[TBL] [Abstract][Full Text] [Related]
66. Significance of Smoking as a Postoperative Prognostic Factor in Patients with Non-small Cell Lung Cancer.
Hanagiri T; Sugio K; Mizukami M; Ichiki Y; Sugaya M; Yasuda M; Takenoyama M; Yasumoto K
J Thorac Oncol; 2008 Oct; 3(10):1127-32. PubMed ID: 18827608
[TBL] [Abstract][Full Text] [Related]
67. Swedish Lung Cancer Radiation Study Group: predictive value of age at diagnosis for radiotherapy response in patients with non-small cell lung cancer.
Holgersson G; Hoye E; Bergqvist M; Ekman S; Nyman J; Helsing M; Friesland S; Holgersson M; Ekberg L; Blystad T; Ewers SB; Mörth C; Löden B; Henriksson R; Bergström S
Acta Oncol; 2012 Jul; 51(6):759-67. PubMed ID: 22793039
[TBL] [Abstract][Full Text] [Related]
68. Pre-treatment prognostic factors in stage III non-small cell lung cancer patients receiving combined modality treatment.
Bonomi P; Gale M; Rowland K; Taylor SG; Purl S; Reddy S; Lee MS; Phillips A; Kittle CF; Warren W
Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):247-52. PubMed ID: 1846847
[TBL] [Abstract][Full Text] [Related]
69. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications.
Okami J; Higashiyama M; Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Miyaoka E;
J Thorac Oncol; 2009 Oct; 4(10):1247-53. PubMed ID: 19609223
[TBL] [Abstract][Full Text] [Related]
70. Research on correlation between tumor-stroma ratio and prognosis in non-small cell lung cancer.
Zhang X; Zhang Y; Sun Z; Ma H
Minerva Med; 2019 Dec; 110(6):590-592. PubMed ID: 30843605
[No Abstract] [Full Text] [Related]
71. Sex differences in the prognosis after surgery for esophageal squamous cell carcinoma and adenocarcinoma.
Kauppila JH; Wahlin K; Lagergren P; Lagergren J
Int J Cancer; 2019 Mar; 144(6):1284-1291. PubMed ID: 30168595
[TBL] [Abstract][Full Text] [Related]
72. Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection.
Shimada Y; Saji H; Yoshida K; Kakihana M; Honda H; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
J Thorac Oncol; 2012 Aug; 7(8):1263-70. PubMed ID: 22673056
[TBL] [Abstract][Full Text] [Related]
73. Cox Regression and Parametric Models: Comparison of How They Determine Factors Influencing Survival of Patients with Non-Small Cell Lung Carcinoma.
Khaksar E; Askarishahi M; Hekmatimoghaddam S; Vahedian-Ardakani H
Asian Pac J Cancer Prev; 2017 Dec; 18(12):3389-3393. PubMed ID: 29286608
[TBL] [Abstract][Full Text] [Related]
74. Mediastinal lymph node examination and survival in resected early-stage non-small-cell lung cancer in the surveillance, epidemiology, and end results database.
Osarogiagbon RU; Yu X
J Thorac Oncol; 2012 Dec; 7(12):1798-1806. PubMed ID: 23154551
[TBL] [Abstract][Full Text] [Related]
75. Sex-Dependent Staging in Non-Small-Cell Lung Cancer; Analysis of the Effect of Sex Differences in the Eighth Edition of the Tumor, Node, Metastases Staging System.
Wainer Z; Wright GM; Gough K; Daniels MG; Russell PA; Choong P; Conron M; Ball D; Solomon B
Clin Lung Cancer; 2018 Nov; 19(6):e933-e944. PubMed ID: 30206043
[TBL] [Abstract][Full Text] [Related]
76. Differences between squamous cell carcinoma and adenocarcinoma of the lung: are adenocarcinoma and squamous cell carcinoma prognostically equal?
Kawase A; Yoshida J; Ishii G; Nakao M; Aokage K; Hishida T; Nishimura M; Nagai K
Jpn J Clin Oncol; 2012 Mar; 42(3):189-95. PubMed ID: 22210923
[TBL] [Abstract][Full Text] [Related]
77. High p-Smad2 expression in stromal fibroblasts predicts poor survival in patients with clinical stage I to IIIA non-small cell lung cancer.
Chen Y; Xing P; Chen Y; Zou L; Zhang Y; Li F; Lu X
World J Surg Oncol; 2014 Nov; 12():328. PubMed ID: 25373709
[TBL] [Abstract][Full Text] [Related]
78. Season of diagnosis and survival of advanced lung cancer cases--any correlation?
Oguz A; Unal D; Kurtul N; Aykas F; Mutlu H; Karagoz H; Cetinkaya A
Asian Pac J Cancer Prev; 2013; 14(7):4325-8. PubMed ID: 23991997
[TBL] [Abstract][Full Text] [Related]
79. Use of the proposals of the international association for the study of lung cancer in the forthcoming edition of lung cancer staging system to predict long-term prognosis of operated patients.
Rena O; Massera F; Robustellini M; Papalia E; Delfanti R; Lisi E; Pirondini E; Turello D; Casadio C
Cancer J; 2010; 16(2):176-81. PubMed ID: 20404615
[TBL] [Abstract][Full Text] [Related]
80. Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial.
Reck M; Kaiser R; Mellemgaard A; Douillard JY; Orlov S; Krzakowski M; von Pawel J; Gottfried M; Bondarenko I; Liao M; Gann CN; Barrueco J; Gaschler-Markefski B; Novello S;
Lancet Oncol; 2014 Feb; 15(2):143-55. PubMed ID: 24411639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]